Iron-binding proteins in thyroid tumours. An immunocytochemical study.

Area of Science:

• Endocrinology
• Oncology
• Pathology

Background:

• Iron-binding proteins like lactoferrin and transferrin play crucial roles in cellular metabolism and are implicated in various neoplastic processes.
• Understanding the expression patterns of these proteins in thyroid lesions can provide insights into tumor behavior and aid in diagnosis.

Purpose of the Study:

• To investigate the expression of lactoferrin, transferrin, and ferritin in different types of thyroid tumors and normal thyroid tissue.
• To evaluate the potential utility of lactoferrin and transferrin as diagnostic markers for differentiating benign from malignant thyroid lesions of follicular cell origin.

Main Methods:

• Immunocytochemistry was employed to detect the presence and localization of lactoferrin, transferrin, and ferritin.
• The study included follicular adenomas, Hürthle cell tumors, follicular carcinomas, papillary carcinomas, anaplastic carcinomas, medullary carcinomas, and normal thyroid tissue.

Main Results:

• Follicular adenomas were negative for all tested iron-binding proteins.
• Hürthle cell tumors, follicular, and papillary carcinomas showed cytoplasmic positivity for lactoferrin and transferrin, but not ferritin.
• Anaplastic carcinomas exhibited mixed results, while medullary carcinomas were consistently negative.

Conclusions:

• Lactoferrin and transferrin expression is associated with malignant thyroid tumors of follicular cell origin.
• These glycoproteins may serve as valuable adjuncts to thyroglobulin in the differential diagnosis of thyroid lesions.
• The differential expression suggests a potential role in meeting the increased iron demands of neoplastic cells.